Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Jean Marie Boher"'
Autor:
Leonor Lopez Almeida, Eric Lambaudie, Clément Brun, Braticevic, Goetgheluck, Charlène Villaron, Patricia Marino, Christophe Zemmour, Cécile Bannier, Jihane Pakradouni, Jean-Marie Boher, Patrick Ben Soussan
Publikováno v:
International Journal of Gynecological Cancer
International Journal of Gynecological Cancer, 2021, 31 (6), pp.920-924. ⟨10.1136/ijgc-2020-002128⟩
International Journal of Gynecological Cancer, 2021, 31 (6), pp.920-924. ⟨10.1136/ijgc-2020-002128⟩
BackgroundPatients undergoing neoadjuvant chemotherapy before surgery for advanced ovarian cancer may have impaired functional capacity, nutritional status, and emotional well-being.Primary objective(s)TRAINING-01 aims to determine if a connected pre
Autor:
Arnaud Guille, Jihane Pakradouni, Max Chaffanet, Séverine Garnier, Christelle Levy, Marie Robert, Jean Marie Boher, Anthony Gonçalves, Cecile Vicier, Cornel Popovici, José Adélaïde, Daniel Birnbaum, Florence Dalenc, Patrick Sfumato, Nadine Carbuccia, Renaud Sabatier, Keyvan Rezai, Nicolas Isambert, Emmanuelle Charafe-Jauffret, François Bertucci, Magali Provansal
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2021, 159, pp.205-214. ⟨10.1016/j.ejca.2021.09.040⟩
European Journal of Cancer, 2021, 159, pp.205-214. ⟨10.1016/j.ejca.2021.09.040⟩
International audience; Background: Hormone-resistant HER2-negative or triple-negative advanced breast cancers (ABC) are routinely treated with paclitaxel chemotherapy. LY2780301 is a dual inhibitor of p70 ribosomal protein S6 kinase and AKT. The TAK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8522dd2e4d78727ec43433cf5ba566f
https://hal.science/hal-03622797
https://hal.science/hal-03622797
Autor:
Marian Gutowski, Jean-Marie Boher, Séverine Racadot, Claire Lemanski, Laure Delmond, Monique Cohen, Julien Barrou, Gilles Houvenaeghel, Agnès Tallet
Publikováno v:
The Breast Journal. 26:2145-2150
This French study reports the 5-year results of partial-breast irradiation using intraoperative radiation therapy (IORT) with 50 kV x-rays, in select early breast cancer patients. We report a retrospective analysis of 676 consecutive early breast can
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, Philippe Gabelle, Julia Pernaut, Francesco Del Piano, Gauthier D’Halluin, Stéphane Lantheaume, Emile Darai, Bassoodéo Beedassy, Caroline Dhainaut-Speyer, Xavier Martin, Sophie Girard, Richard Villet, Emilie Monrigal, Théophile Hoyek, Jean-François Le Brun, Pierre-Emmanuel Colombo, Agnès Tallet, Jean-Marie Boher, SERC trial group
Publikováno v:
npj Breast Cancer
npj Breast Cancer, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
npj Breast Cancer, Nature, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
NPJ Breast Cancer
npj Breast Cancer, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
npj Breast Cancer, Nature, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩
NPJ Breast Cancer
Based on results of clinical trials, completion ALND (cALND) is frequently not performed for patients with breast conservation therapy and one or two involved sentinel nodes (SN) by micro- or macro-metastases. However, there were limitations despite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e7778cc48965295aea1e88ef37dd72b
https://hal.sorbonne-universite.fr/hal-03406273
https://hal.sorbonne-universite.fr/hal-03406273
Autor:
Jean Marie Boher, Jérôme Winkler, Marc Giovannini, Fabrice Caillol, Antoine Debourdeau, Christophe Zemmour, Jean-Philippe Ratone, Christian Pesenti, Claire Decoster
Publikováno v:
Endoscopic Ultrasound
Endoscopic Ultrasound, 2021, 10 (2), pp.124-133. ⟨10.4103/EUS-D-20-00159⟩
Endoscopic Ultrasound, 2021, 10 (2), pp.124-133. ⟨10.4103/EUS-D-20-00159⟩
International audience; Background and objectives: Concomitant biliary and duodenal malignant obstruction are a severe condition mainly managed by duodenal and biliary stenting, which can be performed simultaneously (SAMETIME) or in two distinct proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::688633fd5f2a6b68f38ee2df07acfb86
https://hal.science/hal-03660601
https://hal.science/hal-03660601
Autor:
Gilles Houvenaeghel, Houssein El Hajj, Julien Barrou, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, François Desmons, Agnès Tallet, Jean-Marie Boher, the SERC Trial Group
Publikováno v:
Cancers, Vol 12, Iss 2924, p 2924 (2020)
Cancers
Volume 12
Issue 10
Cancers
Volume 12
Issue 10
Simple Summary After the results of many trials, it is now accepted to omit axillary dissection in selected patients with limited axillary involvement. However, the external validity of these trials is questionable. Our study aimed to evaluate the ac
Autor:
Pernelle Lavaud, Etienne Suc, Gwenaelle Gravis, Alain Ravaud, Gael Deplanque, Igor Latorzeff, Florence Joly, Nicole Tubiana-Mathieu, Muriel Habibian, Jean-Marie Boher, Brigitte Laguerre, Christian Platini, Stéphane Oudard, Jean Marc Ferrero, Jean-François Berdah, Stéphane Culine, Frederic Rolland, Frank Priou, Clemence Legoupil, Damien Pouessel, Ivan Krakowski, Philippe Beuzeboc, Ali Hasbini, Jérôme Dauba, Jean-Christophe Eymard, Claude El Kouri, Marjorie Baciuchka, Stéphanie Foulon, Remy Delva, Loic Mourey, Michel Soulié, Claude Linassier, Guilhem Bousquet, Christine Theodore, Sylvie Zanetta, Gabrielle Tergemina-Clain, Karim Fizazi, Jean-Pascal Machiels
Publikováno v:
European Urology
European Urology, 2017, ⟨10.1016/j.eururo.2017.09.022⟩
European Urology, 2017, ⟨10.1016/j.eururo.2017.09.022⟩
Background Androgen deprivation therapy (ADT) plus docetaxel is the standard of care in fit men with metastatic castration-naive prostate cancer (mCNPC) following results from GETUG-AFU 15, CHAARTED, and STAMPEDE. No data are available on the efficac
Autor:
Mathilde Guerin, Aurélie Autret, Keyvan Rezai, Alice Hervieu, Jean-Marc Extra, Nicolas Isambert, Magali Provansal, Emmanuelle Charafe-Jauffret, François Bertucci, Patrice Viens, Renaud Sabatier, Anthony Gonçalves, Jacques Camerlo, Mario Campone, François Lokiec, Jihane Pakradouni, Jean-Marie Boher
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
European Journal of Cancer, Elsevier, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩
Background Phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin pathway is frequently activated in HER2-positive breast cancer and may play a major role in resistance to trastuzumab. Buparlisib is a pan-class-I PI3K inhibitor with p
Autor:
Edouard Forcade, Jean Marie Boher, Didier Blaise, Florent Malard, Ana Berceanu, Raynier Devillier, Sabine Furst, Peffault De Latour Régis, Sylvie François, Anne Huynh, Samia Harbi, Claude-Eric Bulabois, Amandine Charbonnier, Eric Hermet, Marie-Thérèse Rubio, Patrice Chevallier, Thomas Cluzeau, Mohamad Mohty
Publikováno v:
Blood. 136:35-36
Background Allogeneic stem cell transplantation (Allo-SCT) from a matched related donor (MRD) is rarely performed for older patients because of lack of such a donor. Matched unrelated donor (MUD) is considered as an alternative for this population wi
Autor:
Laurys Boudin, Carole Tarpin, Emmanuelle Charafe-Jauffret, Michel Resbeut, Patrice Viens, Renaud Sabatier, Eric Lambaudie, Anthony Gonçalves, Patrick Sfumato, Claude Lemarie, Boris Calmels, Gilles Houvenaeghel, Magali Provansal, Agnès Tallet, Christian Chabannon, Jean-Marie Boher, Jean-Marc Extra, François Bertucci
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2017, 104 (4), pp.332-343. ⟨10.1016/j.bulcan.2016.12.007⟩
Bulletin du Cancer, 2017, 104 (4), pp.332-343. ⟨10.1016/j.bulcan.2016.12.007⟩
Bulletin du Cancer, John Libbey Eurotext, 2017, 104 (4), pp.332-343. ⟨10.1016/j.bulcan.2016.12.007⟩
Bulletin du Cancer, 2017, 104 (4), pp.332-343. ⟨10.1016/j.bulcan.2016.12.007⟩
Resume Introduction Les etudes evaluant la chimiotherapie a haute dose avec autogreffe de cellules-souches hematopoietiques (HDC-ACSH) dans la prise en charge des cancers du sein metastatiques (CSM), localement avances (CSLA) ou inflammatoires (CSI)